Human investigations have identified a substantial presence of IL-17-secreting γδT cells in lesions of psoriasis patients, with dermal γδT cells serving as a major source of IL-17 and CCR6 following IL-23 activation in the skin. This evidence concerns the gene IL17A and psoriasis.